common uncommon ailments example researchers profiled populations organisms people ulcerative colitis forms ulcers colon linked changes gut flora building results summer pharmaceutical giant johnson johnson j&j announced $ 6.5 million deal second genome microbiome start develop treatments current approaches center anti inflammatory drugs immunosuppressant medications surgery unsuccessful therapy directly alters microbiome potentially create fewer effects fend infections road j&j deal watershed says rita colwell holds health appointments university maryland johns hopkins university moment new biotechnology critically important moves area academic interest companies founded notes step big pharma money arrives new treatments big improvement current attempts improve microbiome consist mainly fecal